Urinary tract infections (UTIs) are the most common bacterial infection worldwide, affecting 150 million people annually \[[@B1]\]. Most UTIs occur in outpatients, and outpatients with UTIs (8.6 million each year) account for most of the outpatients in the United States \[[@B2]\]. UTI prevalence varies across age groups \[[@B3]\]; however, its prevalence by age group in Korea is yet to be thoroughly investigated \[[@B4][@B5]\].

The diagnostic gold standard for UTIs is urine culture to confirm the presence of bacteria, which takes a minimum of two days. Consequently, empirical antibiotics are typically prescribed for most patients before diagnosis, which increases antibiotic use and resistance \[[@B6]\].

Various alternatives to urine culture, such as dipstick urinalysis, microscopic sediment urinalysis, and automated urinalysis, are used to screen for UTIs. Dipstick urinalysis identifies nitrites and leukocyte esterase in urine. Its sensitivity and specificity were 75% and 82%, respectively, when nitrite or leukocyte esterase positive results are obtained \[[@B7]\]. Microscopic sediment urinalysis aids in UTI diagnosis by identifying bacteria (B-A-C) or white blood cells (WBC). Its sensitivity and specificity were 68.2% and 87.8%, respectively, when pyuria is present during UTI diagnosis \[[@B7]\], and 78.8% and 97.8%, respectively, when confirmed by bacteriuria \[[@B8]\]. Both dipstick urinalysis and microscopic sediment urinalysis are time-consuming and labor-intensive, and their outcomes can be influenced by the technician. Thus, a method of automated urinalysis has emerged \[[@B9]\].

The UF-1000i system (Sysmex, Kobe, Japan) is a type of flow cytometer that combines the impedance method with the identification and quantification of microscopic materials suspended in the urine \[[@B10]\]. UF-1000i has the advantage of having a separate bacterial analysis channel. It can analyze 64,000 particles per sample within 50--75 seconds and analyze 80--100 urine samples per hour. Consequently, it would be appropriate for UTI screening for a high number of urine samples \[[@B11]\]. The default parameters for classifying UTIs, defined as \>20 WBCs/µL combined with \>50 B-A-C/µL, are not suitable for practical diagnosis. Although some studies have suggested a unified cutoff value for UTI diagnosis for specific ages \[[@B12][@B13][@B14][@B15]\], a useful cutoff value is yet to be determined. No studies in Korea have determined a UF-1000i cutoff.

We retrospectively reviewed medical records to evaluate the usefulness of age-specific cutoffs of UF-1000i for rapid screening of UTIs. Our study was approved by the Institutional Review Board of Chung-Ang University Hospital, Seoul, Korea (1802-005-16146). From January 2010 to December 2017, 7,443 urine samples were analyzed. They were obtained from 7,443 outpatients at Chung-Ang University Hospital, aged between 0.5 months and 103 years (4,023 males and 3,420 females). None had received antibiotics within the previous four weeks. Repeat visits of the same outpatients were excluded. Outpatients over 15 years were classified into five age groups (15--24 years, 25--44 years, 45--64 years, 65--74 years, and ≥75 years) on the basis of a previous study on UTI prevalence \[[@B3]\]. Outpatients younger than 15 years were classified into two groups (\<4 years and 4--14 years) as samples were collected using a different method for those \<4 years.

Samples were collected in a sterile container using the midstream clean catch method except for outpatients \<4 years, for whom urine was collected using a sterile pouch \[[@B16][@B17]\]. Samples were analyzed using UF-1000i and urine culture. The UF-1000i analysis was completed within 30 minutes of collection. When 0.8-mL urine samples are loaded on the UF-1000i system along with buffer and two polymethine dyes, the suspended particles in the urine are counted and classified as WBCs, red blood cells (RBCs), epithelial cells, crystals, casts, and B-A-C within one min. Urine culture was performed using a 1-µL loop to streak urine onto blood agar and MacConkey agar plates. The culture medium was inoculated within two hours and was analyzed following incubation at 37℃, 5% CO~2~ for 24--48 hours. When the culture result indicated that the bacterial load was greater than 10^5^ colony forming units (CFU)/mL, bacterial identification and antimicrobial susceptibility analysis was performed using a Vitek 2 system (BioMérieux Inc., Durham, NC, USA). WBC, B-A-C, and RBC counts from UF-1000i were compared with culture results.

Statistical analysis was performed using IBM SPSS Statistics for Windows, version 22.0 (IBM Corp., Armonk, NY, USA). Based on the culture results, we generated age-dependent ROC curves and compared them to determine the usefulness of UF-1000i and the cutoffs for each age group. We chose a cutoff with high sensitivity that represents the maximum sum of sensitivity and specificity. The most appropriate sensitivity was ≥90%, the minimum sensitivity was ≥70%, and the minimum specificity was ≥60%. Additional analyses were performed on the three most commonly identified strains in urine culture. The UF-1000i WBC, B-A-C, and RBC counts of each strain were expressed as medians. The Kruskal-Wallis test was used to determine whether they significantly differed among strains, and Mann-Whitney U test was used to compare them between pairs of strains. *P*\<0.05 was considered statistically significant.

Of the 7,443 samples analyzed, 1,398 were culture positive, 5,774 were culture negative, and 271 were contaminated. [Table 1](#T1){ref-type="table"} shows the bacterial species and the number of identified culture positive samples. In all age groups, the area under the curve (AUC) was highest for the sum of the WBC and B-A-C graphs ([Fig. 1](#F1){ref-type="fig"}). The cutoffs of the sums of the WBC and B-A-C graphs in each age group were presented. The AUC for all groups over 15 years of age was \>0.9 and with \>90% sensitivity.

The three most commonly identified strains in urine culture were *Escherichia coli* (937 samples), *Klebsiella pneumoniae* (86 samples), and *Enterococcus faecalis* (72 samples). *E. coli* and *K. pneumoniae* infections resulted in higher B-A-C and WBC counts than *E. faecalis* infections ([Fig. 2](#F2){ref-type="fig"}). Post-hoc analyses showed the following: *E. coli* vs *E. faecalis* (WBC \[*P*\<0.001\], B-A-C \[*P*\<0.001\], RBC \[*P*=0.065\]), *E. faecalis* vs *K. pneumoniae* (WBC \[*P*=0.011\], B-A-C \[*P*\<0.001\], RBC \[*P*=0.818\]), and *E. coli* vs *K. pneumoniae* (WBC \[*P*=0.577\], B-A-C \[*P*=0.752\], RBC \[*P*=0.063\]).

Our results showed that UF-1000i is suitable for UTI screening in outpatients ≥15 years but not in outpatients \<15 years. This may be due to problems associated with collecting urine samples from younger outpatients and the possibility of a high contamination rate. Studies in other countries have not considered UTI prevalence by age \[[@B12][@B13][@B14][@B15]\]. However, we showed that applying a single cutoff to all ages is not appropriate for UTI screening because the value varies with age.

Further, if UF-1000i can be used to obtain additional information on bacteria besides screening for UTIs, it may enable the use of empirical antibiotics before confirmatory culture results can be obtained. Monsen et al. \[[@B18]\] compared the B-A-C, WBC, and RBC counts identified by UF-1000i between various uropathogens. They reported high bacterial and WBC counts for *E. coli* (348 WBCs/µL, 17,914 bacteria/µL) and *Klebsiella* species (160 WBCs/µL, 24,240 bacteria/µL). In contrast, infection by Enterococci, including *E. faecalis*, had low bacterial counts (2,103/µL, *P*\<0.05) \[[@B18]\]. Our results were consistent with those of Monsen et al. \[[@B18]\] and may be due to the low measurement of gram-positive bacteria, which are present in clusters or chains. Although there were insufficient samples in our analysis to provide an accurate cutoff for distinguishing between gram-positive and gram-negative bacteria, analysis of additional results in subsequent studies could aid in the selection of antibiotics before the final culture results are available. Due to lack of information on the UTI prevalence in Korea, we divided age groups based on data from other countries. If the age-specific prevalence of UTIs in the Korean population is established, it will be possible to obtain more useful results for this population through age-specific analysis.

In conclusion, it is useful for applying the age-specific cutoffs in UF-1000i for UTI screening, thereby preventing antibiotic abuse and reducing antibiotic resistance. Its B-A-C and WBC counts may facilitate selection of empirical antibiotics by distinguishing between gram-positive and gram-negative bacteria.
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![UF-1000i (Sysmex, Kobe, Japan) ROC curves by age. The sum of B-A-C and WBC graphs showed the highest AUC, so the cutoff of this graph is the most suitable for screening. The optimal ROC curve values (AUC, cutoff, sensitivity and specificity) for each age group were as follows: \<4 years (0.790, 74.75/µL, 77.2% and 65.7%), 4--14 years (0.759, 42.9/µL, 81.0% and 65.1%), 15--24 years (0.908, 297.10/µL, 95.1% and 71.7%), 25--44 years (0.902, 395.65/µL, 90.2% and 74.9%), 45--64 years (0.908, 135.65/µL, 90.2% and 72%), 65--74 years (0.916, 67.95/µL, 94.1% and 67.8%), and ≥75 years (0.912, 96.5/µL, 92.8% and 71.1%).\
Abbreviations: WBC, white blood cell; B-A-C, bacteria; AUC, area under the curve.](alm-39-322-g001){#F1}

![Graph of median WBC vs B-A-C counts determined by UF-1000i (Sysmex, Kobe, Japan) in outpatients with a urinary tract infection confirmed to be caused by *Escherichia coli* (937 samples), *Klebsiella pneumoniae* (86 samples), and *Enterococcus faecalis* (72 samples). The distribution range (95% confidence interval, minimum, maximum, interquartile range) is as follows: *E. coli* B-A-C (11,765.0--14,186.4/µL, 2.0/µL, 99,086.0/µL, 17,826.1/µL), *E. coli* WBC (1,073.3--1,464.4/µL, 0.0/µL, 32,723.0/µL, 1,007.4/µL); *E. faecalis* B-A-C (1,836.6--5,964.5/µL, 0.0/µL, 53,597.0/µL, 3,016.4/µL), *E. faecalis* WBC (285.4--847.1/µL, 1.0/µL, 6,779.0/µL, 332.6/µL); *K. pneumoniae* B-A-C (10,532.2--18,205.2/µL, 2.0/µL, 80,533.0/µL, 20,834.0/µL), and *K. pneumoniae* WBC (582.3--2,037.0/µL, 1.0/µL, 31,392.0/µL, 1,081.3/µL).\
Abbreviations: WBC, white blood cell; B-A-C, bacteria.](alm-39-322-g002){#F2}

###### Strains identified in urine cultures

![](alm-39-322-i001)

  Strain^\*^                            N       Age group (yr)                               
  ------------------------------------- ------- ---------------- ---- ---- ----- ----- ----- -----
  *Escherichia coli*                    937     90               21   42   166   264   173   181
  *Klebsiella pneumoniae*               86      17               1    1    7     14    17    29
  *Enterococcus faecalis*               72      8                5    6    5     9     17    22
  *Proteus mirabilis*                   37      8                1    1    3     14    4     6
  *Streptococcus agalactiae*            27      \-               \-   1    2     6     11    7
  *Citrobacter freundii*                24      13               \-   \-   \-    1     6     4
  *Lactobacillus species*               23      \-               1    3    15    4     \-    \-
  *Pseudomonas aeruginosa*              22      1                2    1    2     3     6     7
  *Coagulase negative Staphylococcus*   19      2                2    2    3     5     3     2
  *Enterobacter aerogenes*              16      9                \-   \-   2     1     1     3
  *Enterobacter cloacae*                13      5                \-   \-   1     \-    1     6
  *Staphylococcus aureus*               13      1                \-   \-   1     6     3     2
  *Klebsiella oxytoca*                  11      7                \-   \-   \-    \-    \-    4
  *Enterococcus faecium*                10      4                \-   1    1     \-    1     3
  *Streptococcus viridans group*        10      2                1    1    1     2     3     \-
  Gram-negative bacteria                36      9                5    1    2     5     5     9
  Gram-positive bacteria                42      4                3    1    13    12    4     5
  Total                                 1,398   180              42   61   224   346   255   290

^\*^Species with count \<10 were grouped together.
